Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5786_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contributors
- •Preface
- •1. Physics and instrumentation
- •Introduction
- •Sound
- •Short History of the Development of Ultrasound in Medicine
- •Near Field and Far Field
- •Focusing
- •Sound, Waves and Propagation
- •One Transducer for Each Purpose
- •The Ultrasound Beam
- •Resolution
- •Measurement
- •Time Gain Compensation
- •Artifacts
- •Edge Shadows
- •Attenuation Shadows
- •Enhancement
- •Reverberations
- •References
- •Further reading
- •2. Biological effects and safety aspects
- •Introduction
- •Acoustic Output of Diagnostic Ultrasound Scanners
- •Tissue Warming by Diagnostic Ultrasound
- •Non-Thermal Mechanisms and their Safety Implications
- •Gas Body Effects of Diagnostic Ultrasound
- •Other Mechanical Bioeffects Mechanisms
- •Evidence from Epidemiology
- •The Management of Safety
- •The Users' Responsibility
- •Thermal indices
- •Mechanical index
- •The Manufacturers' Obligations
- •Safety Practice
- •Diagnostic Ultrasound During the First Trimester
- •Scanning During the Second and Third Trimesters
- •Obstetric Scanning on Patients with Fever
- •Conclusion
- •References
- •3. Scanning techniques in obstetrics and gynaecology
- •Introduction
- •General Aspects
- •Empty or Full Bladder
- •Patient Information
- •The Examination Table
- •Bimanual Pelvic Examination Preceding the Scan
- •Equipment
- •Orientation
- •Scanning Routine
- •Obstetric Scanning
- •Biophysical profile
- •Gynaecological Scanning
- •The uterus
- •The cervix
- •The myometrium
- •The endometrium
- •Adnexal Masses
- •Peritoneal Fluid
- •Urinary Bladder
- •Other Findings
- •Colour Doppler Studies
- •Screening for Ovarian Masses
- •Transperineal and Transrectal Scanning
- •Ultrasound-Guided Puncture Procedures
- •Conclusion
- •References
- •4. Investigation of early pregnancy
- •Introduction
- •Description of the Sonoanatomic Development
- •Measurements of the Embryo/Early Fetus
- •Extraembryonic Structures: The Three Sacs
- •Multiple Pregnancy: Determination of Chorionicity and Amnionicity
- •Evaluation of Early Pregnancy Failure
- •Early Pregnancy Loss
- •Gestational sac (chorionic cavity) and amniotic cavity
- •Yolk sac
- •Haematoma
- •Heart rate
- •Trophoblastic Disease
- •Complete hydatidiform mole
- •Partial hydatidiform mole
- •Invasive hydatidiform mole
- •Choriocarcinoma
- •Ectopic Pregnancy
- •Early Anomalies
- •Standardization of Transvaginal and Transabdominal Imaging in Gynaecology
- •Imaging in Medicine
- •References
- •5. Normal fetal anatomy at 18–22 weeks
- •Introduction
- •Scan Guidelines
- •Normal Fetal Anatomy
- •Brain/Calvarium
- •Transthalamic view
- •Transventricular view
- •Heart
- •Transcerebellar view
- •Face and Neck
- •Spine
- •Lungs and Thorax
- •Abdomen
- •Anterior Abdominal Wall
- •Urinary Tract
- •Genitalia
- •Skeleton and Extremities
- •Conclusion
- •References
- •6. Amniotic fluid and placental localization
- •Amniotic Fluid
- •Amniotic Fluid Physiology
- •Fetal urinary production
- •Lung fluid
- •Flow across the chorionic plate
- •Amniotic Fluid Volume
- •Methods of assessment
- •Normal amniotic fluid volume values
- •Abnormal amniotic fluid volumes
- •Oligohydramnios
- •Polyhydramnios
- •Conclusions
- •Placenta Localization
- •Embryology
- •Functional anatomy
- •Development of the placenta as evaluated by ultrasound technology
- •Indications for the Location of the Placenta
- •Various locations of the placenta
- •Placenta praevia
- •Suggested management protocol for suspected placenta praevia
- •Placental Morphology
- •Conclusion
- •References
- •7. Assessment of the placenta and umbilical cord
- •Introduction
- •Major Structural Abnormalities of the Placenta
- •Congenital Abnormalities
- •Abnormalities of placentation
- •Placenta extrachorialis
- •Placenta accreta
- •Placental tumours
- •Mesenchymal tumours
- •Gestational trophoblastic tumours (GTD)
- •Secondary Abnormalities
- •Vascular abnormalities
- •Thrombosis and infarcts
- •Haematomas
- •Major Structural Abnormalities of the Umbilical Cord
- •Congenital Abnormalities
- •Abnormalities of the cord insertion
- •Single umbilical artery (SUA) syndrome
- •Cord tumours
- •Secondary Abnormalities
- •Vascular abnormalities
- •Haematomas and thrombosis
- •Vascular abnormalities
- •Abnormal cord position
- •References
- •8. Examining the cervix by transvaginal ultrasound
- •Introduction
- •Transvaginal Ultrasound of the Cervix Predicts Preterm Delivery
- •Measurement Technique
- •Transvaginal Ultrasound of the Cervix in the Clinical Judgement of Preterm Labour
- •Treatment of Cervical Incompetence
- •Prophylactic Cerclage or Transvaginal Follow-Up of the Cervix
- •Prophylactic Treatment with Progesterone in Pregnant Women with Short Cervix
- •Conclusion
- •References
- •9. Fetal biometry, estimation of gestational age, assessment of fetal growth
- •Principles of Fetal Biometry
- •Aims of Fetal Biometry
- •The Reference Values
- •Patient Selection and Study Design
- •Longitudinal and Cross-Sectional Studies
- •Sample Size
- •Displaying Data and Curve Fitting
- •Linear regression analysis
- •Curvilinear regression analysis
- •The coefficients of correlation
- •The F test
- •Prediction of Date and Size
- •The Confidence Limits
- •Dating
- •Menstrual, Conceptual and Gestational Age
- •Errors of Measurements
- •The Accuracy of Dating
- •Biometric Parameters
- •Gestational Sac
- •Crown–Rump Length
- •Head Measures
- •Abdominal Size
- •Limbs
- •Other Measurements and Dating
- •Data Report
- •Fetal Weight Estimation
- •Biometric Ratios
- •Other Parameters
- •Evaluation of Fetal Growth
- •Definition
- •Unsolved Problems
- •Screening and Diagnostic Strategies
- •Fetal Growth Restriction
- •Macrosomia
- •Fetal Biometry, Anomalies and Syndromes
- •Conclusion
- •References
- •10. Prenatal diagnosis of fetal anomalies
- •An Introduction to Congenital Anomalies
- •Central Nervous System Anomalies
- •Neural Tube Defects
- •Ventriculomegaly
- •Holoprosencephaly
- •Agenesis of the Corpus Callosum
- •Dandy–Walker Complex
- •Microcephaly
- •Destructive Cerebral Lesions
- •Choroid Plexus cysts
- •Craniofacial Anomalies
- •Facial Clefts
- •Ocular and Orbital Defects
- •Cardiac Anomalies
- •Atrial and Ventricular Septal Defects
- •Atrioventricular septal defects
- •Heterotaxy
- •Univentricular Heart
- •Aortic Stenosis
- •Coarctation, Tubular Hypoplasia and Interruption of the Aortic Arch
- •Hypoplastic Left Heart Syndrome
- •Pulmonary Stenosis and Pulmonary Atresia
- •Conotruncal Malformations
- •Ebstein's Anomaly and Tricuspid Valve Dysplasia
- •Echogenic Foci
- •Cardiac Dysrhythmias
- •Thoracic Anomalies
- •Hyperechogenic and Cystic Lungs
- •Pleural effusions
- •Diaphragmatic Hernia
- •Anomalies of the Abdominal Wall and Gastrointestinal Tract
- •Omphalocele
- •Gastroschisis
- •Body Stalk Anomaly
- •Bladder Exstrophy and Cloacal Exstrophy
- •Oesophageal Atresia
- •Duodenal Atresia
- •Intestinal Obstruction
- •Echogenic Bowel
- •Meconium Peritonitis
- •Abdominal Cysts
- •Anomalies of the Kidneys and Urinary Tract
- •Renal Agenesis
- •Cystic Kidneys
- •Urinary Tract Enlargement
- •Skeletal Anomalies
- •Fetal Tumours
- •Hydrops Fetalis
- •Chromosomal Defects
- •Ultrasound Findings with Chromosomal Aberrations
- •Individual Risk Assessment of Chromosomal Aberrations by the use of Midtrimester Ultrasound
- •Absent or hypoplastic nasal bone (<2.5 mm)
- •Nuchal oedema or fold more than 6mm
- •Hyperechogenic bowel
- •Short femur
- •Echogenic foci in the heart
- •Choroid plexus cysts
- •Mild hydronephrosis
- •Accuracy of Ultrasound in the Detection of Fetal Anomalies
- •Conclusion
- •Note
- •References
- •11. Evaluation of fetal and uteroplacental blood flow
- •Introduction
- •Uterine Artery Doppler
- •Umbilical Artery Doppler
- •Middle Cerebral Artery Doppler
- •MCA in Fetal Growth Restriction
- •MCA in Fetal Anaemia
- •Ductus Venosus
- •Umbilical Vein
- •Doppler in Twin Pregnancies
- •References
- •12. Invasive procedures in obstetrics
- •Introduction
- •Counselling
- •Training
- •The Procedures
- •Asepsis
- •Chorionic Villous Sampling
- •Chorionic villus sampling in multiple gestations
- •Safety
- •Amniocentesis
- •Safety
- •Amniocentesis in multiple gestations
- •Fetal Blood Sampling
- •Technique
- •Complications
- •Intrauterine Fetal Blood Transfusion
- •Complications
- •Fetal Shunts
- •Techniques
- •Complications
- •Delivery and shunt removal
- •Outcome
- •Diagnostic and Operative Fetoscopy
- •Pregnancy Reduction in Multifetal Pregnancies
- •Technique
- •Selective Fetocide for Fetal Abnormality
- •Conclusion
- •References
- •13. Multiple pregnancies
- •Introduction
- •First-Trimester Ultrasound
- •Pregnancy Dating
- •Number of Fetuses
- •Chorionicity and Amnionicity
- •Nuchal Translucency
- •Invasive Diagnostic Procedures
- •Growth Discrepancy and Fetal Monitoring
- •Malformations and Fetal Demise
- •Twin–Twin Transfusion Syndrome
- •Twin Reversed Arterial Perfusion
- •Monoamniotic Twins
- •Higher-Order Multiple Pregnancies
- •References
- •14. Three-dimensional and four-dimensional ultrasound application in prenatal diagnosis
- •Introduction
- •Volume Acquisition
- •Static 3D
- •Real-Time 3D or 4D Ultrasound
- •Spatial and Temporal Image Correlation
- •Volume Data Display
- •Single Plane of Choice, Multiplanar Orthogonal Planes or Multiple Tomographic Parallel Slices
- •Surface Mode Rendering
- •Maximum Mode Rendering
- •Minimum Mode Rendering
- •Inversion Mode Rendering
- •Glass Body Mode Rendering
- •Volume Calculation
- •Conclusion
- •References
- •15. Fetal movement patterns and behavioural states
- •Introduction
- •Methodology
- •The Emergence of Fetal Movement Patterns
- •Body Movements in Normal Pregnancy
- •Fetal Breathing in Normal Pregnancy
- •Normal Development of Fetal Behavioural States
- •Altered Brain or Muscular Development
- •Intrauterine Growth Retardation (IUGR)
- •Maternal Diabetes
- •Preterm Contractions and/or Rupture of Membranes
- •Drugs, Medication, Stress and Fetal Stimulation
- •Conclusion
- •References
- •16. Normal gynaecological anatomy (uterus, tubes, ovaries)
- •Introduction
- •Normal Ultrasound Morphology of the Cervix Uteri
- •Normal Ultrasound Morphology of the Uterus in Women of Fertile Age
- •Normal Ultrasound Morphology of the Ovaries in Women of Fertile Age
- •Normal Ultrasound Morphology of the Uterus and Ovaries in Postmenopausal Women
- •Normal Ultrasound Morphology of the Uterus and Ovaries in Menopausal Transition
- •Normal Uterine and Ovarian Vascularization as Assessed by Doppler Ultrasound Technique
- •The Tubes
- •The Pouch of Douglas
- •Hydrosonography
- •Hystero-Contrast Salpingosonography (HyCoSy)
- •Acknowledgements
- •References
- •17. Gynaecological pathology: the uterus
- •Introduction
- •Congenital Uterine Anomalies
- •Uterine Fibroids
- •Uterine Sarcoma
- •Adenomyosis
- •Endometrial Polyps
- •Endometrial Hyperplasia and Malignancy
- •Conclusion
- •References
- •18. Gynaecological pathology: tubes and ovaries
- •Ovaries
- •Benign and Malignant Ovarian Cysts: General Considerations
- •Tumour Size
- •Tumour Structure
- •Cyst Wall and Septal Wall Thickness
- •Echo-Dense Foci and Acoustic Shadowing
- •Echogenicity
- •Morphology Scoring Systems
- •Benign and Malignant Neoplasms of the Ovary
- •Dysfunctional ovarian cysts
- •Follicle cysts
- •Corpus luteum cysts
- •Thecalutein cysts
- •Endometriosis
- •Epithelial ovarian tumours
- •Serous ovarian tumours
- •Mucinous ovarian tumours
- •Fibromas and fibrothecomas
- •Germ cell tumours
- •Adnexal Torsion
- •Tubes
- •Non-Infectious Diseases of the Fallopian Tubes
- •Tubal pregnancy
- •Fallopian tube carcinoma
- •Hydrosalpinx
- •Infectious Diseases of the Fallopian Tubes
- •Note
- •References
- •19. Doppler ultrasonography in gynaecology
- •Introduction
- •Adnexal Masses
- •Other Pelvic Pathology
- •In Vitro Fertilization
- •References
- •20. Medico-legal implications of ultrasound imaging in obstetrics and gynaecology
- •Introduction
- •The Legal Process
- •The Trial Process
- •Reducing the Risk of Litigation
- •Never undertake a type of scan with which you are not entirely familiar (unless in a learning environment)
- •Record sample images (and be able to retrieve them)
- •Always act professionally and responsibly
- •Be aware of the common traps (and avoid them!)
- •If the scan is suboptimal, say so and explain why
- •Ensure the equipment is appropriate
- •Defending a Claim
- •Recording Images
- •Documentation
- •Conclusion
- •21. Ethics and patient information
- •Introduction
- •Ethics, Medical Ethics and Ethical Principles
- •The Principle of Beneficence
- •The Principle of Respect for Autonomy
- •The Interaction of Beneficence and Respect for Autonomy in Clinical Judgement and Practice
- •The Ethical Concept of the Fetus as a Patient
- •The viable fetal patient
- •The previable fetal patient
- •Clinical Topics
- •Competence and Referral in Ultrasound Examination
- •Routine Ultrasound Screening and Risk Assessment of Pregnant Women
- •Disclosure of Results of Ultrasound Examinations
- •Confidentiality of Findings
- •Conclusion
- •References
- •Test yourself – questions and answers
- •Chapter 2 Biological Effects and Safety Aspects
- •Chapter 4 Investigation of Early Pregnancy
- •Chapter 5 Normal Fetal Anatomy at 18–22 Weeks
- •Chapter 6 Amniotic Fluid and Placental Localization
- •Chapter 10 Prenatal Diagnosis of Fetal Anomalies
- •Chapter 12 Invasive Procedures in Obstetrics
- •Chapter 13 Multiple Pregnancies
- •Chapter 17 Gynaecological Pathology: The Uterus
- •Chapter 19 Doppler Ultrasonography in Gynaecology
- •Chapter 21 Ethics and Patient Information
- •Answers
- •Index

and intrauterine bleeding with formation of a subchorionic haematoma (see below).
Circumvallate placentation is therefore accompanied by a risk of premature rupture
of the membrane, vaginal bleeding and preterm onset of labour. This form of placentation is also associated with an increased incidence of low-birthweight infants.
9,13
The obstetric risks linked with circumvallate placentas has never been evaluated prospectively. Multiple subamniotic sonolucent areas of various size and
shape, located in the periphery of the placenta, are the main ultrasound features
of this form of placentation.9 However, the accuracy of sonography of the placenta for revealing circumvallation appears to be limited.
8
Placenta accreta
This has been defined as a placenta with abnormal adherence, either in whole or
in part, to the uterine wall.
6,16
This abnormality is characterized by myometrial
invasion by the villi and occurs when the decidua basalis is partially or completely
absent. According to the degree of myometrial invasion, this condition is subdivided into placenta accreta vera, when the villi are simply attached to the myometrium, placenta increta, when the villi deeply invade the myometrium, and placenta
percreta, when the villi penetrate the entire thickness of the uterine wall.
16
Placenta accreta is a rare but very serious abnormality. All conditions or procedures which affect the integrity of the internal uterine walls, such as caesarean
section and other uterine surgery, curettage, sepsis or fibroids, are predisposing
factors for abnormal villous penetration.6 In many patients there is a combination of aetiological factors and the association of high parity with prior caesarean scars and anterior low placental insertion (praevia) is a particular risk.
Placentas accreta have an overall maternal and fetal mortality of around 10%
due to antepartum or postpartum bleeding, uterine rupture and uterine inversion. Placenta percreta is clearly the most dangerous condition, with a perinatal mortality rate approaching 96%.
6,16
On ultrasound, the decidual interface
between placenta and myometrium (hypoechoic retroplacental zone) is absent
at the level of the abnormal villous penetration.
4,6,16,29
Most placentas accreta can be detected as early as 11–14 weeks of gestation
in most at-risk patients by visualization of irregular vascular spaces within the
placenta basal area.4 Colour Doppler sonography highlights areas of increased
vascularity with dilated blood vessels crossing the placenta and uterine wall.
16,29
In addition, in placenta percreta, an irregular uterine serosa is found in greyscale ultrasonography and thinning of the uterine wall, found in magnetic resonance imaging, contributes to the diagnosis.29 The diagnosis of placenta accreta
is rarely achieved antenatally by routine ultrasound examination.6 However,
by contrast with placenta circumvallate, the prenatal diagnosis of this condition allows the surgical team to demarcate which areas of the placenta are
accreta, increta or percreta before surgery and prepare for a caesarean hysterectomy and more extensive pelvic surgery if a partial resection is impossible.
This approach has not been investigated prospectively on many patients but
there is little doubt that prenatal diagnosis of major placenta increta and percreta will reduce fetal and maternal perinatal mortality allowing transfer to
centres that are equipped for major pelvic surgery and intensive care.
Assessment of the placenta and umbilical cord
123

Placental tumours
Mesenchymal tumours
Chorioangioma or placental hemangioma is the most common benign tumour of
the placenta with an incidence at delivery of 0.5–1% of placentas examined.
The incidence of large chorioangiomas is lower and varies from 1 in 8000 to 1 in
50,000 pregnancies.16 Chorioangiomas are hamartomas, which arise as a malformation of the primitive angioblastic tissue of the placenta.
There are two main histopathological types of chorioangiomas: angiomatous,
which are formed of numerous blood vessels, and cellular, which consist of loose
mesenchymal tissue, containing a few ill-formed vessels. Degenerative changes such
as necrosis, calcification, hyalinization or myxoid changes are frequently present in
large tumours.9 Most chorioangiomas are small, single, round, encapsulated and intraplacental. They are occasionally observed during routine ultrasound examination14
and are likely to be discovered only by histopathological examination. Large chorioangiomas are of variable shape, divided by fibrous septa, and most commonly protrude from the fetal surface of the placenta near the cord insertion.9 These tumours
Ultrasound in obstetrics and gynaecology
are well circumscribed, have a different echogenicity from the rest of the placental
tissue and have been documented sonographically from 16 weeks of gestation.14
Chorioangiomas can be complicated by fetal hydrops due to the chronic shunting
of large volumes of fetal blood through the tumour or to polyhydramnios.
development of polyhydramnios is independent of the size of the tumour but rather
linked to its vascular nature.
14,30
The fetal risk depends more on the proportion of
angiomatous versus myxoid tissue inside the tumour than on its exact size.
Thus ultrasound examination of the vascularization of the tumour is a pivotal
determining factor of pregnancy outcome (Fig. 7.1). If the tumour is avascular,
no specific complications should be expected. If the tumour is vascularized, and
in particular if it contains numerous large vessels, serial ultrasound and Doppler
examinations are warranted to detect polyhydramnios and early features of fetal
congestive heart failure. Novel intrauterine treatment options include intravascular transfusion, fetoscopic laser devascularization, microcoil embolization, and
9,16
9,14
The
14
124
Fig. 7.1 Heterogeneous vascular placental mass at 30 weeks, protruding from the fetal
plate near the cord insertion (star). The pregnancy was complicated by polyhydramnios.
Pathological examination demonstrated a vascular chorioangioma.

intravascular injection of absolute alcohol. Quantitative flow data obtained using
three-dimensional power Doppler may indicate altered haemodynamics in the
tumour which can influence the management.
28
Gestational trophoblastic tumours (GTD)
Hydatidiform transformation (Fig. 7.2) of the villous tissue is a common finding in
placental trophoblastic tumours. Complete or classic hydatidiform moles (CHM)
are described as a generalized swelling of the villous tissue, diffuse trophoblastic hyperplasia and no embryonic or fetal tissue.3 Classically, patients with CHM
present with vaginal bleeding, uterine enlargement greater than expected for gestational age and abnormally high level of maternal serum human chorionic gonadotropin (MShCG). Medical complications include pregnancy-induced hypertension
(PIH), hyperthyroidism, hyperemesis, anaemia and the development of ovarian
theca-lutein cyst. With earlier diagnosis, the incidence of these complications has
decreased. Molar changes can now be detected from the second month of pregnancy by ultrasound which typically reveals a uterine cavity filled with multiple
sonolucent areas of varying size and shape (‘snow-storm appearance’) without associated embryonic or fetal structure.
18,21
Theca-lutein cysts secondary to the very
high MShCG levels may be diagnosed in up to 30% of cases producing either soap
bubble or spoke wheel appearance of the ovaries, which are enlarged. Elevated
Assessment of the placenta and umbilical cord
Fig. 7.2 Typical ‘Swiss cheese’ appearance of the placenta on ultrasound corresponding to
hydatidiform transformation in a partial mole.
125

MShCG levels, combined with these specific sonographic features, are highly indicative of the presence of hydatidiform mole, even before the final histopathological
diagnosis is confirmed. Ultrasound features of CHM may be different at earlier gestations and accuracy of diagnosis varies between studies. The ultrasound diagnosis
of complete mole usually poses little problem from the third month of pregnancy
onward and can be made prenatally in around 80% of cases.
2,13,29
Partial hydatidiform moles (PHM) refer to the combination of a fetus with
localized placental molar degenerations, characterized by focal swelling of the
villous tissue – focal trophoblastic hyperplasia.19 The abnormal villi are being
scattered within macroscopically normal placental tissue, which tends to retain
its shape. Partial moles are usually triploid and of diandric origin, having two
sets of chromosomes from paternal origin and one from maternal origin. Most
have a 69,XXX or 69,XXY genotype derived from a haploid ovum with either
reduplication of the paternal haploid set from a single sperm or, less frequently,
from dispermic fertilization. Triploidy of digynic origin, due to a double maternal contribution, is not associated with placental hydatidiform changes. Vaginal
bleeding in the first or second trimester with a total incidence of 47% is the most
Ultrasound in obstetrics and gynaecology
common maternal symptom reported in both types of triploidies.19 The phenotypic expression of both diandric and digynic triploidies includes growth restriction and disturbance of organogenesis that becomes obvious in fetuses surviving
into the second trimester. From 16 weeks, almost all triploid fetuses have at least
one measurement below the normal range and more than 70% present with severe
growth restriction.19 Structural fetal defects are observed antenatally in about
93% of cases. The most common are abnormalities of the hands, bilateral cerebral
ventriculomegaly, heart anomalies and micrognathia. Triploid partial moles are
not associated with specific fetal anomaly but almost always with symmetrical
growth restriction. Classically, triploid partial mole presents on ultrasound as an
enlarged placenta (thickness >4 cm at 18–22 weeks) containing multicystic avascular sonolucent spaces (see Fig. 7.2) – ‘Swiss cheese’ appearance.
Following uterine evacuation, 18–29% of patients with a CHM and 1% of those
with a PHM will develop a persistent trophoblastic tumour.
3,19
If the incidence of
maternal complication has been reduced by an early diagnosis, the incidence of persistent GTD has remained unchanged since the introduction of routine ultrasound
examination during pregnancy. This highlights the importance of training sonographers working in early pregnancy units in the detection of placental molar changes
as many cases of complete and partial moles will present as miscarriages. MShCG
is significantly higher in both CHM and PHM and, in conjunction with transvaginal
ultrasound, may provide the screening test required.
126
SECONDARY ABNORMALITIES
Vascular abnormalities
Thrombosis and infarcts
Both lesions are usually found during the third trimester of pregnancy.1 Placental
thromboses are the result of focal coagulation of blood in the intervillous spaces

and occur more frequently in pregnancies complicated by rhesus isoimmuniza-
9,15,17
tion.
Large hypoechoic areas with low flow laterally and relatively high
flow in the central part on real-time imaging can be observed in the early stages
of the development of an intervillous thrombosis. Abnormal haemodynamic
flow in the intervillous space may result from the failure of the cotyledon to
expand in response to the increasing flow of the corresponding uteroplacental artery and compression of the surrounding villi which gradually atrophy as
fibrin is laid down in the periphery.15 This process causes a progressive increase
of the echogenicity of the lesion. Finally the maternal blood coagulates in
the placental tissue, obliterating, focally, the intervillous circulation.
Placental infarcts are the result of obstruction of a uteroplacental artery leading to
focal degeneration of the overlying villous tissue.
15,17
Extensive infarcts are found in pregnancies complicated by pre-eclampsia or essential hypertension and are associated with
an increase in perinatal mortality and intrauterine growth retardation. Sonographically,
placental infarcts appear as large intraplacental areas, irregular and hyperechoic in the
acute stage and isoechoic in a more advanced stage.
9,17
Identifying thrombo-occlusive
placental lesions before the development of pregnancy complications may prove useful
in the design of trials to study the effectiveness of heparin in the prevention of clinical
complications resulting from thrombo-occlusive uteroplacental disease.
9
Haematomas
Extravasation of maternal or fetal blood can result in a localized collection of blood or
haematoma forming in the placenta. Such lesions may be subamniotic, subchorionic
or retroplacental and can be identified on prenatal ultrasound examination.
5,20
The terminology used to describe placental vascular lesions is confusing, with
ultrasound descriptions often unrelated to the pathological findings. Various terms
such as subchorionic cyst, membranous cyst, thrombotic cyst and subchorionic
haemorrhage have been used in the literature to describe lesions of the fetal plate
of the placenta. A subchorionic or retroplacental haematoma reflects bleeding of
maternal origin and is identified sonographically as a hypoechoic area between the
chorion and uterine wall. Such lesions are seen in more than 10% of pregnancies,
commonly in the first trimester, and may carry an increased risk of miscarriage, stillbirth, preterm labour and abruptio placentae.
9,17
On the other hand, subamniotic
haematoma are found situated under the amniotic layer covering the fetal (chorionic) plate of the placenta and result from the rupture of fetal vessels branching
from the cord (Fig. 7.3). These are considerably less common, with the majority
reported in the third trimester or as a result of excessive traction on the umbilical
cord at delivery.17 The sonographic appearance is of a single mass protruding from
the fetal plate and surrounded by a thin membrane. While the newly formed clot
is echogenic, with time the lesion becomes less so as the clot resolves.
Assessment of the placenta and umbilical cord
MAJOR STRUCTURAL ABNORMALITIES OF THE UMBILICAL CORD
The umbilical cord anatomy can often be visualized from 12 weeks' gestation by
grey-scale imaging but a precise diagnosis of a particular cord abnormality may be
127

Fig. 7.3 Hypoechoic mass protruding from the fetal plate of the placenta (star) and
corresponding after delivery to subamniotic haematoma due to the rupture of a fetal vessel.
difficult and time consuming before 18–20 weeks. Various factors such as oligo-
Ultrasound in obstetrics and gynaecology
hydramnios or multiple loops in the cord can make accurate visualization of the
cord vessels impossible, even near term.17 High-resolution colour Doppler imaging has an important role in early and accurate diagnosis of cord abnormalities
and is also of clinical value in viewing invasive procedures such as amniocentesis
or cordocentesis.
128
CONGENITAL ABNORMALITIES
Abnormalities of the cord insertion
Velamentous insertion of the cord or placenta velamentosa is a well-defined pathological entity with a frequency of around 1% of pregnancies.17 From a clinical
point of view, attachment of the cord to the extraplacental membranes is important because of the risk of severe fetal haemorrhage during labour. Antenatal
diagnosis of attachment of the cord to the membranes rather than the placental
mass can be easily performed before labour by means of grey-scale and colour
Doppler imaging.
at routine obstetric ultrasound has the potential to identify pregnancies with
velamentous insertion and, therefore, those at risk for obstetric complications,
including vasa praevia.
Single umbilical artery (SUA) syndrome
The absence of one umbilical artery (Fig. 7.4) is amongst the most common congenital fetal malformations with an incidence of approximately 1% of all deliveries.17 The highest incidence of SUA is found among western Europeans and there is
no evidence of familial tendency for this anomaly. SUA occurs three to four times
more frequently in twins and almost invariably accompanies the acardia malformation and sirenomelia or caudal regression syndrome.
increase of the incidence of velamentous insertion of the cord among SUA infants.
17,27
Systematic assessment of the placental cord insertion site
17
There is also a sixfold

Fig. 7.4 Longitudinal view of an umbilical cord containing one vein and one artery.
Fetal major anatomical defects are largely responsible for the high fetal and
neonatal loss from this pathology.23 Fetal malformations are present in about 50%
of cases of SUA and can affect any organ system. The comparison of sonographic
and postnatal findings in cases of SUA syndrome has shown that minor malformations of the musculoskeletal and cardiovascular systems or of the genitourinary tract are often misdiagnosed by ultrasonography, in particular when they are
isolated.17 The discovery of a SUA in the perinatal period justifies a detailed ultrasound examination of the neonate to exclude minor anomalies of internal organs
such as the kidney or heart, which may lead to deleterious sequelae if untreated
until late infancy. The antenatal discovery of a SUA together with another fetal
structural abnormality should raise the question of antenatal chromosome invasive testing,23 in particular in early pregnancy24 when the diagnosis of structural
defect is less accurate. However, it is most likely that, as for many other isolated
fetal defects, an isolated SUA does not increase the risk for trisomy 21.17 Thus,
the SUA is not a specific marker of chromosomal abnormalities and the higher
incidence of SUA found in trisomies 13 and 1824 is probably only related to the
higher incidence in these cases of major fetal defects which are known to be associated with the aplasia or atrophy of one of the umbilical arteries.
The detection rate of SUA remains low in routine ultrasound.7 However, the
incidence of fetal growth restriction (FGR) is significantly elevated among fetuses
with a SUA and may be present without any other congenital anomalies in about
20% of cases.17 Since the incidence of FGR is about 10% in the third trimester of
pregnancy then 1 in 10 neonates with a low birthweight may have a SUA. The
presence of a single umbilical artery is associated with a poorer perinatal outcome compared to that in fetuses with three vessels in the cord.7 Recognizing the
importance of this cord anomaly in counselling and management of pregnancies
should provide the stimulus to improve detection rates.
Assessment of the placenta and umbilical cord
Cord tumours
Umbilical cord tumours are infrequent perinatal findings and are always benign.
From a pathological point of view, primary cord tumours can be divided into
129

Fig. 7.5 Transverse view of a cord tumour containing dense tissue and pseudocysts and
corresponding to a cord angiomyxoma.
angiomyxomas or haemangiomas derived from embryonic vessels, teratomas
derived from germ cells and vestigial cysts derived from remnants of the allantois
Ultrasound in obstetrics and gynaecology
or the omphalomesenteric duct.17 A cord angiomyxoma appears sonographically
as a heterogeneous mass made of a strong echogenic area, embedding the umbilical
vessels12 and surrounded by large echo-poor areas (Fig. 7.5). The prenatal diagnosis
of a cord teratoma has rarely been documented but this type of tumour is mainly
composed of dense tissue26 and appears echogenic on ultrasound. Conversely, vestigial cysts appear sonographically as a single fluid-filled mass.17 Vestigial cysts
and pseudocysts can sometimes be associated with small abdominal wall defects
and a precise early prenatal diagnosis can be more difficult to establish.10 These
embryonic cysts are usually small but some may exceed 5 cm in size and appear
as a poorly reflective round mass adjacent to or within the cord. Colour Doppler
shows no blood flow within the mass.17 The prevalence of these cysts is around 3%
in the first trimester and is an important differential diagnosis as more than 20% of
cases are associated with fetal chromosomal or structural defects, especially when
located close to the placental insertion of the cord.
25
130
SECONDARY ABNORMALITIES
Vascular abnormalities
Haematomas and thrombosis
Spontaneous cord haematomas are occasional perinatal findings and are usually
located near the fetal umbilicus.17 Mechanical trauma of the cord such as prolapse, torsion, strangulation or dissecting aneurysm are all potential causes of cord
haematoma. At ultrasound examination, the cord appears markedly thickened,
sausage-shaped and extremely echogenic. Thrombosis of one or more umbilical cord vessels is a rare complication with an incidence of approximately 0.08%
among placentas examined prospectively at delivery.17 Thrombosis of the umbilical vein occurs more frequently than thrombosis of one or both arteries and perinatal morbidity or mortality is more likely with umbilical artery thrombosis than

with umbilical vein thrombosis. Thrombosis of the umbilical vessels may also be
secondary to localized increased resistance in the umbilical circulation in cases
of torsion, compression and knotting of haematoma. Intense echogenic material
within the lumen of the umbilical vessels is the main sonographic finding.
17
Vascular abnormalities
Abnormal cord position
Looping of the cord may occur around the fetal neck, body or shoulder17 and
can be diagnosed by sonography. Although in singleton pregnancies looping of
the cord around the neck is an uncommon cause of fetal death, in monoamniotic
twins a significant portion of the high mortality can be attributed to umbilical
cord problems. Short-term fetal complications of the nuchal cord theoretically
include variable fetal heart rate decelerations during the first and second stages of
labour and lower mean umbilical artery and venous pH at birth. However, because
of the small size of these studies the clinical significance of a single nuchal cord
remains undetermined. The sensitivity of around 90% for colour Doppler imaging in detecting the presence of a nuchal cord increases with advancing gestation
and is always higher than that of grey-scale imaging.11 Colour mapping allows
single loops to be differentiated from multiple loops of nuchal cord. However,
the sensitivity of the routine ultrasound diagnosis of a nuchal cord is low prior
to induction of labour at term.22 Furthermore, a nuchal cord does not appear to
increase the risk of caesarean section or poor neonatal outcome. The low ultrasound detection rate of a nuchal cord limits its use in decision making prior to
induction of labour in high-risk pregnancies.
11,22
Assessment of the placenta and umbilical cord
References
1. Alkazaleh F, Viero S, Simchen M et al.
Ultrasound diagnosis of severe thrombotic
placental damage in the second trimester:
an observational study. Ultrasound Obstet
Gynecol 2004;23:472–476
2. Benson CB, Genest DR, Bernstein MR,
Soto-Wright V, Goldstein DP, Berkowitz RS.
Sonographic appearance of first trimester
complete hydatidiform moles. Ultrasound
Obstet Gynecol 2000;16:188–191
3. Berkowitz RS, Goldstein DP. Chorionic
tumors. N Engl J Med 1996;335:1740–1748
4. Comstock CH, Love JJ Jr, Bronsteen RA
et al. Sonographic detection of placenta
accreta in the second and third trimesters
of pregnancy. Am J Obstet Gynecol
2004;190:1135–1140
5. Deans A, Jauniaux E. Prenatal diagnosis
and outcome of subamniotic hematomas.
Ultrasound Obstet Gynecol 1998;11:367–377
6. Gielchinsky Y, Rojansky N, Fasouliotis
SJ, Ezra Y. Placenta accreta – summary of
10 years: a survey of 310 cases. Placenta
2002;23:210–214
7. Gornall AS, Kurinczuk JJ, Konje JC.
Antenatal detection of a single umbilical
artery: does it matter? Prenat Diagn
2003;23:117–123
8. Harris RD, Wells WA, Black WC et al.
Accuracy of prenatal sonography for
detecting circumvallate placenta. Am J
Roentgenol 1997;168:1603–1608
9. Jauniaux E, Campbell S. Sonographic
assessment of placental abnormalities. Am J
Obstet Gynecol 1990;163:1650–1658
10. Jauniaux E, Donner C, Thomas C, Francotte
J, Rodesch F, Avni E. Umbilical cord
pseudocyst in trisomy 18. Prenat Diagn
1998;8:557–563
11. Jauniaux E, Mawissa C, Peellaerts C,
Rodesch F. Nuchal cord in normal third
trimester pregnancy: a color Doppler
imaging study. Ultrasound Obstet Gynecol
1992;2:417–419
131

12. Jauniaux E, Moscoso G, Chitty L, Gibb D,
Driver M, Campbell S. An angiomyxoma
involving the whole length of the umbilical
cord: prenatal diagnosis by ultrasonography.
J Ultrasound Med 1990;9:419–422
13. Jauniaux E, Nicolaides KH. Early
ultrasound diagnosis and follow-up of molar
pregnancies. Ultrasound Obstet Gynecol
1997;9:17–21
14. Jauniaux E, Ogle R. Colour Doppler
imaging in the diagnosis and management of
chorioangiomas. Ultrasound Obstet Gynecol
2000;15:463–467
15. Jauniaux E, Ramsay B, Campbell S.
Ultrasonographic investigation of placental
morphology and size during the second
trimester of pregnancy. Am J Obstet
Gynecol 1994;170:130–137
16. Jauniaux E, Toplis PJ, Nicolaides KH.
Sonographic diagnosis of a non-praevia
placenta accreta. Ultrasound Obstet
Ultrasound in obstetrics and gynaecology
Gynecol 1996;7:58–60
17. Jauniaux E. The placenta. In: Dewbury
K, Meire H, Cosgrove D, Farrant P (eds)
Clinical ultrasound. A comprehensive text,
2nd edn, vol 3. Churchill Livingstone,
London, 2001: 527–556
18. Jauniaux E. Ultrasound diagnosis and
follow-up of gestational trophoblastic
disease. Ultrasound Obstet Gynecol
1998;11:367–377
19. Jauniaux E. Partial moles: from postnatal to
prenatal diagnosis. Placenta 1999;20:379–388
20. Johns J, Hyett J, Jauniaux E. Obstetric
outcome after threatened miscarriage with
and without a hematoma on ultrasound.
Obstet Gynecol 2003;102:483–487
21. Lazarus E, Hulka CA, Siewert B, Levine D.
Sonographic appearance of early complete
molar pregnancies. J Ultrasound Med
1999;18:589–593
22. Peregrine E, O'Brien P, Jauniaux E.
Ultrasound detection of nuchal cord prior
to labor induction and the risk of cesarean
section. Ultraswound Obstet Gynecol
2004;25:160–164
23. Prucka S, Clemens M, Craven C, McPherson
E. Single umbilical artery: what does it
mean for the fetus? A case-control analysis
of pathologically ascertained cases. Genet
Med 2004;6:54–57
24. Rembouskos G, Cicero S, Longo D,
Sacchini C, Nicolaides KH. Single umbilical
artery at 11–14 weeks' gestation: relation
to chromosomal defects. Ultrasound Obstet
Gynecol 2003;22:567–570
25. Ross JA, Jurkovic D, Zosmer N, Jauniaux R,
Hacket E, Nicolaides KH. Umbilical cord
cysts in early pregnancy. Obstet Gynecol
1997;89:442–445
26. Satge DC, Laumond MA, Desfarges F,
Chenard MP. An umbilical cord teratoma
in a 17-week-old fetus. Prenat Diagn
2001;21:284–288
27. Sepulveda W, Rojas I, Robert JA,
Schnapp C, Alcalde JL. Prenatal detection
of velamentous insertion of the umbilical
cord: a prospective color Doppler
ultrasound study. Ultrasound Obstet
Gynecol 2003;21:564–569
28. Shih JC, Ko TL, Lin MC, Shyu MK, Lee CN,
Hsieh FJ. Quantitative three-dimensional
power Doppler ultrasound predicts the
outcome of placental chorioangioma.
Ultrasound Obstet Gynecol 2004;24:
202–206
29. Taipale P, Orden MR, Berg M, Manninen H,
Alafuzoff I. Prenatal diagnosis of placenta
accreta and percreta with ultrasonography,
color Doppler, and magnetic resonante
imaging. Obstet Gynecol 2004;104:537–540
30. Zalel Y, Weisz B, Gamzu R, Schiff E,
Shalmon B, Achiron R. Chorioangiomas
of the placenta: sonographic and Doppler
flow characteriztics. J Ultrasound Med
2002;21:909–913
132
Соседние файлы в папке Библиотека им академика М.И. Перельмана
